Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
- PMID: 25990290
- PMCID: PMC4717391
- DOI: 10.1136/annrheumdis-2015-207526
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
Erratum in
-
Correction.Ann Rheum Dis. 2016 May;75(5):946. doi: 10.1136/annrheumdis-2015-207526corr1. Ann Rheum Dis. 2016. PMID: 27060159 Free PMC article. No abstract available.
Abstract
Objective: A systematic literature review (SLR; 2009-2014) to compare a target-oriented approach with routine management in the treatment of rheumatoid arthritis (RA) to allow an update of the treat-to-target recommendations.
Methods: Two SLRs focused on clinical trials employing a treatment approach targeting a specific clinical outcome were performed. In addition to testing clinical, functional and/or structural changes as endpoints, comorbidities, cardiovascular risk, work productivity and education as well as patient self-assessment were investigated. The searches covered MEDLINE, EMBASE, Cochrane databases and Clinicaltrial.gov for the period between 2009 and 2012 and separately for the period of 2012 to May of 2014.
Results: Of 8442 citations retrieved in the two SLRs, 176 articles underwent full-text review. According to predefined inclusion/exclusion criteria, six articles were included of which five showed superiority of a targeted treatment approach aiming at least at low-disease activity versus routine care; in addition, publications providing supportive evidence were also incorporated that aside from expanding the evidence provided by the above six publications allowed concluding that a target-oriented approach leads to less comorbidities and cardiovascular risk and better work productivity than conventional care.
Conclusions: The current study expands the evidence that targeting low-disease activity or remission in the management of RA conveys better outcomes than routine care.
Keywords: Disease Activity; Rheumatoid Arthritis; Treatment.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4717391/bin/annrheumdis-2015-207526f01.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4717391/bin/annrheumdis-2015-207526f02.gif)
Comment in
-
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.Ann Rheum Dis. 2016 Jul;75(7):e35. doi: 10.1136/annrheumdis-2015-209094. Epub 2016 Mar 29. Ann Rheum Dis. 2016. PMID: 27026690 No abstract available.
-
Response to: 'Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update' by Goswami et al.Ann Rheum Dis. 2016 Jul;75(7):e36. doi: 10.1136/annrheumdis-2016-209499. Epub 2016 Apr 4. Ann Rheum Dis. 2016. PMID: 27045105 No abstract available.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3. Cochrane Database Syst Rev. 2019. PMID: 31125448 Free PMC article.
-
Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key.Nat Rev Rheumatol. 2015 Sep;11(9):509-11. doi: 10.1038/nrrheum.2015.98. Epub 2015 Jul 21. Nat Rev Rheumatol. 2015. PMID: 26195337
-
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.Ann Rheum Dis. 2016 Jan;75(1):3-15. doi: 10.1136/annrheumdis-2015-207524. Epub 2015 May 12. Ann Rheum Dis. 2016. PMID: 25969430 Free PMC article. Review.
-
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.Ann Rheum Dis. 2010 Apr;69(4):638-643. doi: 10.1136/ard.2009.123976. Ann Rheum Dis. 2010. PMID: 20237123 Free PMC article. Review.
Cited by
-
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.Clin Rheumatol. 2024 Jun;43(6):1823-1832. doi: 10.1007/s10067-024-06967-8. Epub 2024 Apr 18. Clin Rheumatol. 2024. PMID: 38634966 Free PMC article.
-
Rheumatoid arthritis, disease-modifying antirheumatic drugs and risk of major osteoporotic fracture: prospective data from the HUNT Study, Norway.RMD Open. 2024 Feb 20;10(1):e003919. doi: 10.1136/rmdopen-2023-003919. RMD Open. 2024. PMID: 38382944 Free PMC article.
-
"How are you?" Perspectives From Patients and Health Care Providers of Text Messaging to Support Rheumatoid Arthritis Care: A Thematic Analysis.ACR Open Rheumatol. 2024 May;6(5):276-286. doi: 10.1002/acr2.11652. Epub 2024 Feb 20. ACR Open Rheumatol. 2024. PMID: 38376004 Free PMC article.
-
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis.Curr Rheumatol Rep. 2024 Mar;26(3):81-88. doi: 10.1007/s11926-023-01129-2. Epub 2023 Dec 29. Curr Rheumatol Rep. 2024. PMID: 38157158 Review.
-
Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis.Front Med (Lausanne). 2023 Nov 20;10:1294247. doi: 10.3389/fmed.2023.1294247. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38053615 Free PMC article.
References
-
- van der Heijde DM, van ‘t Hof M, van Riel PL, et al. . Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical